Consequently, enhancing the sensitivity of chemotherapy by inhibiting the uptake of LAT2-mediated amino acids to reduce CD47 and by enhancing the infiltration and phagocytosis of tumour cells by macrophages has emerged as a potential strategy for the treatment of cancer. The gene discussed is CD47; the disease is neoplasm.